New Horizon Health (FRA:6YZ) Long-Term Debt: €49.0 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6YZ New Horizon Health Ltd FRA:6YZ
35 GF Score
Price €1.62
View Full Analysis

What is New Horizon Health Long-Term Debt?

New Horizon Health FRA:6YZ 35 Long-Term Debt is €49.0 Mil as of Jun. 2023. GuruFocus rates FRA:6YZ with a GF Score™ of 35/100.

New Horizon Health's Long-Term Debt for the quarter that ended in Jun. 2023 was €49.0 Mil.

New Horizon Health's quarterly Long-Term Debt increased from Jun. 2022 (€0.0 Mil) to Dec. 2022 (€24.4 Mil) and increased from Dec. 2022 (€24.4 Mil) to Jun. 2023 (€49.0 Mil).

New Horizon Health's annual Long-Term Debt declined from Dec. 2020 (€5.8 Mil) to Dec. 2021 (€0.0 Mil) but then increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€24.4 Mil).

New Horizon Health  (FRA:6YZ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

New Horizon Health Long-Term Debt Related Terms

New Horizon Health Long-Term Debt Historical Data

* Premium members only.

The historical data trend for New Horizon Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health Long-Term Debt Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Long-Term Debt
0.00 4.76 5.79 0.00 24.37

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 10.27 0.00 0.00 24.37 48.98
FRA:6YZ
35GF Score
New Horizon Health Ltd FRA:6YZ
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €49.0 Mil mean?
New Horizon Health (FRA:6YZ) has a Long-Term Debt of €49.0 Mil as of Jun. 2023.
Is New Horizon Health's Long-Term Debt too high?
New Horizon Health's current Long-Term Debt is €49.0 Mil. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's Long-Term Debt compare to ABT and SYK?
New Horizon Health's Long-Term Debt of €49.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. New Horizon Health's current Long-Term Debt is €49.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (FRA:6YZ) has a current Long-Term Debt of €49.0 Mil. The current Long-Term Debt is €49.0 Mil. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For New Horizon Health (FRA:6YZ), the current Long-Term Debt is €49.0 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for FRA:6YZ

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.62
Price